NIA COVID-19 Response
In this rapidly evolving crisis, NIA supports research into COVID-19 and older adults, particularly why they may be more susceptible to the virus, how they can be most protected, and the social and economic effects of the pandemic on older adults.
In a paper in the New England Journal of Medicine, scientific leaders from the National Institutes of Health, including NIA Director Richard J. Hodes, set forth a framework to increase significantly the number, quality and type of daily tests for detecting SARS-CoV-2, the virus that causes COVID-19, and help reduce inequities for underserved populations that have been disproportionally affected by the disease. NIH established the Rapid Acceleration of Diagnostics (RADx) program to respond to this critical need.
The National Institutes of Health’s Rapid Acceleration of Diagnostics (RADxSM) Program
The RADx initiative is a national call for scientists and organizations to bring their innovative ideas for new COVID-19 testing approaches and strategies. NIA has been an integral part of these initiatives, especially the RADx Underserved Populations (RADx-UP) program, which strives to understand the factors associated with disparities in COVID-19 morbidity and mortality. Learn more about RADx.
Check this page frequently for updates on NIA’s response to the COVID-19 pandemic.
NIA is Funding Aging Research into COVID-19
In April, NIA published a Notice of Special Interest (NOSI) on NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19), NOT-AG-20-022. Open to NIA, National Institute of Mental Health, and National Institute on Alcohol Abuse and Alcoholism grantees, the NOSI is designed to support administrative and revision supplements in aging biology, behavioral and social research, geriatrics and gerontology and neuroscience related to COVID-19. Learn more about the NOSI in this Inside NIA blog post.
In addition to soliciting applications for administrative supplements, NIA has joined the following Notices, NOSIs, and FOAs originating with other NIH Institutes and Centers:
|Number||Title||Participating Organizations||Release Date||Expiration Date|
|RFA-OD-20-018||OD, NHLBI, NHGRI, NIA, NIDCR, NIDA, NCATS, Common Fund, NCI||August 6, 2020||September 19, 2020|
|RFA-OD-20-014||OD, NIA, NIAAA, NICHD, NCCIH, NCI, NHLBI||August 6, 2020||September 16, 2020|
|NOT-OD-20-152||OD, NIA, NICHD, NIDCD, NIDCR, NINDS, NINR, ORWH||August 6, 2020||September 16, 2020|
|RFA-OD-20-022||OD, NIA, NICHD, NIDCD, NIDCR, NINDS, NINR, NLM, ORWH||August 6, 2020||September 16, 2020|
|PAR-20-243||NIMH, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NIMHD, NCCIH, NCATS, ODP, OBSSR, ORWH, SGMRO||June 26, 2020||March 3, 2021|
|PAR-20-237||NIMHD, NEI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NINR, NCCIH, NCATS, SGMRO, ODP, ORWH||June 17, 2020||December 2, 2020|
|NOT-OD-20-119||OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH||June 12, 2020||September 9, 2020|
|NOT-OD-20-120||OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH||June 12, 2020||September 9, 2020|
|NOT-OD-20-121||OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, National Institute of Allergy and Infectious Diseases (NIAID), NIAMS, NICHD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, National Institute of Neurological Disorders and Stroke (NINDS), NINR, NLM, NCCIH, NCATS, NCI, SGMRO, THRO, OD, ODP, OBSSR, ORWH||June 12, 2020||August 8, 2020|
|NOT-OD-20-118||Office of the Director (OD)||June 10, 2020||N/A|
||NIMHD, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIMH, NCCIH, NCATS, SGMRO, ODP, OBSSR, ORWH||June 5, 2020||December 30, 2020 (NIA Expiration: December 1, 2020)|
||NIMH, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NINR, NIMHD, NCCIH, National Center for Advancing Translational Sciences (NCATS), Sexual and Gender Minority Research Office (SGMRO), OBSSR, ODP, Office of Research on Women's Health (ORWH)||June 5, 2020||December 30, 2020 (NIA Expiration: December 1, 2020)|
|NOT-MH-20-058||NIMH, National Eye Institute (NEI), NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDA, NINR, NCCIH, ODP, OBSSR||June 4, 2020||N/A|
|NOT-MD-20-023||NIMHD, NIA, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Dental and Craniofacial Research (NIDCR), National Institute on Drug Abuse (NIDA), NIEHS, NIMH, National Institute of Nursing Research (NINR), NCCIH, Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP), OBSSR, ORWH||June 3, 2020||N/A|
||NIH Office of Behavioral and Social Sciences Research (OBSSR), National Heart, Lung, and Blood Institute (NHLBI), NIA, NIAAA, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Environmental Health Sciences (NIEHS), NCCIH, National Cancer Institute (NCI)||April 13, 2020||April 1, 2021 (NIA Expiration: December 1, 2020)|
|NOT-AT-20-011||National Center for Complementary and Integrative Health (NCCIH), NIA, NIAAA||April 10, 2020||N/A|
||NIMHD, NIA, NIMH, NIAAA, NINDS||April 9, 2020||May 1, 2021 (NIA Expiration: December 1, 2020)|
||NIMH, NIA, National Institute of Minority Health and Health Disparities (NIMHD), NIAAA||April 9, 2020||April 16, 2021 (NIA Expiration: December 1, 2020)|
|NOT-AG-20-022||National Institute on Aging (NIA), National Institute of Mental Health (NIMH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)||April 2, 2020||May 1, 2021|
Support for COVID-19 Interruptions for Funded Researchers
The pandemic and associated closures at institutions around the world present significant challenges for funded researchers managing existing studies. NIA is working with NIH and other HHS colleagues to help ease this burden and provide guidance and policies to ensure research can continue as much as is safe during the pandemic and resume with minimal negative impact after this crisis is over. After visiting the OER Coronavirus webpage for the latest guidance from NIH, NIA grantees are encourage to contact their program officers with specific questions.